The incidence of diabetes is increasing in the general population. Recent pharmaceutical developments with the glitazones coupled with intense media attention on the control of type 2 diabetes has lead to a wealth of recent research. The author has assembled an internationally renowned team to examine and assess current issues in diabetes.